Key Points
- Dawn Christine Maroney, Alignment Healthcare’s president, sold 30,000 shares on Feb. 17 at an average of $20.63 (proceeds $618,900) and now owns 997,015 shares; she has sold roughly 800,222 shares across multiple transactions since December for about $16.05 million.
- Analysts are largely bullish: the stock has an average MarketBeat rating of "Moderate Buy" with an average price target of $23.32, and several firms recently raised targets (Piper Sandler to $30, JPMorgan to $26, KeyCorp to $28).
- Shares trade near $20.59 with a market capitalization of $4.12 billion, a 1‑year range of $11.63–$23.87, and institutional investors owning about 86% of the company.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $20.63, for a total value of $618,900.00. Following the transaction, the president owned 997,015 shares of the company's stock, valued at $20,568,419.45. The trade was a 2.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Dawn Christine Maroney also recently made the following trade(s):
- On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $22.48, for a total value of $674,400.00.
- On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The stock was sold at an average price of $21.33, for a total transaction of $4,866,482.16.
- On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.03, for a total transaction of $2,003,000.00.
- On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total value of $5,285,991.80.
- On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.01, for a total transaction of $2,267,513.19.
- On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.02, for a total transaction of $333,953.62.
Alignment Healthcare Trading Up 2.0%
Shares of NASDAQ:ALHC opened at $20.59 on Wednesday. The company has a market capitalization of $4.12 billion, a P/E ratio of -171.58, a P/E/G ratio of 5.14 and a beta of 1.16. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The business's 50 day simple moving average is $20.95 and its 200 day simple moving average is $18.23.
Analysts Set New Price Targets
A number of research firms have recently weighed in on ALHC. JPMorgan Chase & Co. raised their price target on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an "overweight" rating in a research note on Thursday, February 5th. Barclays raised their target price on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an "equal weight" rating in a research report on Friday, October 31st. Piper Sandler upped their price target on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an "overweight" rating in a report on Tuesday, January 6th. The Goldman Sachs Group reissued a "buy" rating and set a $22.00 price objective on shares of Alignment Healthcare in a report on Monday, November 3rd. Finally, KeyCorp reaffirmed an "overweight" rating and issued a $28.00 target price on shares of Alignment Healthcare in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $23.32.
Get Our Latest Stock Report on Alignment Healthcare
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Parallel Advisors LLC lifted its stake in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company's stock valued at $33,000 after acquiring an additional 773 shares in the last quarter. Larson Financial Group LLC bought a new position in shares of Alignment Healthcare during the third quarter valued at about $33,000. First Horizon Corp purchased a new position in Alignment Healthcare during the fourth quarter worth about $39,000. SBI Securities Co. Ltd. boosted its holdings in Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company's stock worth $42,000 after purchasing an additional 2,970 shares during the last quarter. Finally, GAMMA Investing LLC grew its position in Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company's stock worth $43,000 after purchasing an additional 987 shares in the last quarter. Institutional investors own 86.19% of the company's stock.
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
